{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:32Z","timestamp":1791297932436,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1124\/dmd.114.062539","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T03:22:49Z","timestamp":1425439369000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Toward Predicting Drug-Induced Liver Injury: Parallel Computational Approaches to Identify Multidrug Resistance Protein 4 and Bile Salt Export Pump Inhibitors"],"prefix":"10.1016","volume":"43","author":[{"given":"Matthew A","family":"Welch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"K\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L. R","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W","family":"Swaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.114.062539_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.114.062539_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.24801","volume":"55","author":"Chai","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/dmd.114.062539_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.062539_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/clpt.2012.164","article-title":"Computational modeling to accelerate the identification of substrates and inhibitors for transporters that affect drug disposition","volume":"92","author":"Ekins","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.062539_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.062539_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recognit Lett"},{"key":"10.1124\/dmd.114.062539_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/mol.113.086967","article-title":"Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4\/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity","volume":"84","author":"Fukuda","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.114.062539_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.tpj.6500451","article-title":"Variability in human hepatic MRP4 expression: influence of cholestasis and genotype","volume":"8","author":"Gradhand","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.114.062539_bib9","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s11095-007-9435-9","article-title":"Computational models to assign biopharmaceutics drug disposition classification from molecular structure","volume":"24","author":"Khandelwal","year":"2007","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.114.062539_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/tx800102e","article-title":"Machine learning methods and docking for predicting human pregnane X receptor activation","volume":"21","author":"Khandelwal","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.114.062539_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/dmd.113.054304","article-title":"Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4","volume":"42","author":"K\u00f6ck","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.062539_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfg217","article-title":"Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats","volume":"76","author":"Kostrubsky","year":"2003","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.114.062539_bib13","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.114.062539_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.114.062539_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.114.062539_bib16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1124\/dmd.112.046599","article-title":"Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics","volume":"40","author":"Nagar","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.062539_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/gast.2002.36587","article-title":"Functional expression of the canalicular bile salt export pump of human liver","volume":"123","author":"No\u00e9","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.114.062539_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1076-6332(98)80208-0","article-title":"Confidence intervals for the receiver operating characteristic area in studies with small samples","volume":"5","author":"Obuchowski","year":"1998","journal-title":"Acad Radiol"},{"key":"10.1124\/dmd.114.062539_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kft197","article-title":"Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP\/ABCB11)","volume":"136","author":"Pedersen","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.114.062539_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/tx5000393","article-title":"In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors","volume":"27","author":"Ritschel","year":"2014","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.114.062539_bib21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/1087057105281365","article-title":"Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up","volume":"10","author":"Rogers","year":"2005","journal-title":"J Biomol Screen"},{"key":"10.1124\/dmd.114.062539_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/labinvest.3780411","article-title":"Tissue distribution and induction of human multidrug resistant protein 3","volume":"82","author":"Scheffer","year":"2002","journal-title":"Lab Invest"},{"key":"10.1124\/dmd.114.062539_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.114.062539_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0707235","article-title":"Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis","volume":"151","author":"Teng","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.114.062539_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.106.027623","article-title":"In silico prediction of pregnane X receptor activators by machine learning approaches","volume":"71","author":"Ung","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.114.062539_bib26","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/jm0303195","article-title":"Classification of kinase inhibitors using a Bayesian model","volume":"47","author":"Xia","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.114.062539_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624102978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624102978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.114.062539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:26:48Z","timestamp":1739906808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624102978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0090955624102978"],"URL":"https:\/\/doi.org\/10.1124\/dmd.114.062539","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward Predicting Drug-Induced Liver Injury: Parallel Computational Approaches to Identify Multidrug Resistance Protein 4 and Bile Salt Export Pump Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.114.062539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}